Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tarkowski, E.
Right arrow Articles by Blennow, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tarkowski, E.
Right arrow Articles by Blennow, K.
Neurology 2000;54:2077-2081
© 2000 American Academy of Neurology


Articles

TNF gene polymorphism and its relation to intracerebral production of TNF{alpha} and TNFß in AD

E. Tarkowski, MD, PhD, A.-M. Liljeroth, MD, Å. Nilsson, A. Ricksten, PhD, P. Davidsson, PhD, L. Minthon, MD, PhD and K. Blennow, MD, PhD

From the Departments of Rheumatology (Dr. Tarkowski), Clinical Neurosciences (Sections of Neurology [Dr. Tarkowski] and Neurochemistry [Drs. Davidsson and Blennow]), and Clinical Chemistry (Dr. Ricksten), University of Göteborg; the Department of Community Medicine and Neuropsychiatric Clinic (Drs. Liljeroth, Nilsson, and Minthon), University of Lund/Malmö; and the Medical Research Council (Dr. Blennow), Stockholm, Sweden.

Address correspondence and reprint requests to Dr. Elisabeth Tarkowski, Department of Rheumatology, Guldhedsgatan 10, S-413 46 Göteborg, Sweden.

OBJECTIVE: To analyze the extent of tumor necrosis factor-{alpha} (TNF{alpha}) and TNFß gene polymorphism in patients with AD and to relate it to intrathecal levels of these cytokines.

METHODS: Analyses of TNF{alpha} and TNFß gene polymorphism were performed using PCR in 52 patients with AD and in 25 control subjects, and the levels of corresponding cytokines were analyzed using ELISA.

RESULTS: Patients with AD displayed significantly higher intrathecal levels of TNF{alpha}, but not TNFß, compared with the control subjects. The levels of these cytokines did not differ significantly in patients displaying different alleles of the TNF gene.

CONCLUSIONS: Results indicate that increased intrathecal production of TNF{alpha} in AD is preferentially controlled by environmental stimuli rather than genetic makeup.

Key words: AD—Tumor necrosis factor-{alpha}—Tumor necrosis factor-ß—Gene polymorphism.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
T. K. Khan and D. L. Alkon
An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin
PNAS, August 29, 2006; 103(35): 13203 - 13207.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
E Tarkowski, N Andreasen, A Tarkowski, and K Blennow
Intrathecal inflammation precedes development of Alzheimer's disease
J. Neurol. Neurosurg. Psychiatry, September 1, 2003; 74(9): 1200 - 1205.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.